You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and Japan Expanded Carrier Screening Market Size, Status and Forecast 2020-2026

Expanded reproductive carrier screening is a more comprehensive carrier screen designed for couples, prior to pregnancy. This screen tests the biological mother and the biological father to determine their chance of having a child affected with one or more inherited genetic conditions. Testing covers over 250 different conditions.
Market Analysis and Insights: Global Expanded Carrier Screening Market
The global Expanded Carrier Screening market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Expanded Carrier Screening market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Expanded Carrier Screening market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Expanded Carrier Screening market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Expanded Carrier Screening market.
Expanded Carrier Screening Breakdown Data by Type
Customized Panel Testing
Predesigned Panel Testing
Expanded Carrier Screening Breakdown Data by Application
Hospitals
Reference Laboratories
Physician Offices & Clinics
Other End Users
Based on regional and country-level analysis, the Expanded Carrier Screening market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Expanded Carrier Screening market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Invitae
Fulgent Genetics
LabCorp
VCGS
Myriad Genetics
Eurofins Scientific
BGI Genomics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Expanded Carrier Screening Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Customized Panel Testing
1.2.3 Predesigned Panel Testing
1.3 Market by Application
1.3.1 Global Expanded Carrier Screening Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Reference Laboratories
1.3.4 Physician Offices & Clinics
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Expanded Carrier Screening Market Perspective (2015-2026)
2.2 Global Expanded Carrier Screening Growth Trends by Regions
2.2.1 Expanded Carrier Screening Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Expanded Carrier Screening Historic Market Share by Regions (2015-2020)
2.2.3 Expanded Carrier Screening Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Expanded Carrier Screening Players by Market Size
3.1.1 Global Top Expanded Carrier Screening Players by Revenue (2015-2020)
3.1.2 Global Expanded Carrier Screening Revenue Market Share by Players (2015-2020)
3.2 Global Expanded Carrier Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Expanded Carrier Screening Revenue
3.4 Global Expanded Carrier Screening Market Concentration Ratio
3.4.1 Global Expanded Carrier Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Expanded Carrier Screening Revenue in 2019
3.5 Key Players Expanded Carrier Screening Area Served
3.6 Key Players Expanded Carrier Screening Product Solution and Service
3.7 Date of Enter into Expanded Carrier Screening Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Expanded Carrier Screening Breakdown Data by Type (2015-2026)
4.1 Global Expanded Carrier Screening Historic Market Size by Type (2015-2020)
4.2 Global Expanded Carrier Screening Forecasted Market Size by Type (2021-2026)

5 Expanded Carrier Screening Breakdown Data by Application (2015-2026)
5.1 Global Expanded Carrier Screening Historic Market Size by Application (2015-2020)
5.2 Global Expanded Carrier Screening Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Expanded Carrier Screening Market Size (2015-2026)
6.2 North America Expanded Carrier Screening Market Size by Type (2015-2020)
6.3 North America Expanded Carrier Screening Market Size by Application (2015-2020)
6.4 North America Expanded Carrier Screening Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Expanded Carrier Screening Market Size (2015-2026)
7.2 Europe Expanded Carrier Screening Market Size by Type (2015-2020)
7.3 Europe Expanded Carrier Screening Market Size by Application (2015-2020)
7.4 Europe Expanded Carrier Screening Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Expanded Carrier Screening Market Size (2015-2026)
8.2 China Expanded Carrier Screening Market Size by Type (2015-2020)
8.3 China Expanded Carrier Screening Market Size by Application (2015-2020)
8.4 China Expanded Carrier Screening Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Expanded Carrier Screening Market Size (2015-2026)
9.2 Japan Expanded Carrier Screening Market Size by Type (2015-2020)
9.3 Japan Expanded Carrier Screening Market Size by Application (2015-2020)
9.4 Japan Expanded Carrier Screening Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Expanded Carrier Screening Market Size (2015-2026)
10.2 Southeast Asia Expanded Carrier Screening Market Size by Type (2015-2020)
10.3 Southeast Asia Expanded Carrier Screening Market Size by Application (2015-2020)
10.4 Southeast Asia Expanded Carrier Screening Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Invitae
11.1.1 Invitae Company Details
11.1.2 Invitae Business Overview
11.1.3 Invitae Expanded Carrier Screening Introduction
11.1.4 Invitae Revenue in Expanded Carrier Screening Business (2015-2020))
11.1.5 Invitae Recent Development
11.2 Fulgent Genetics
11.2.1 Fulgent Genetics Company Details
11.2.2 Fulgent Genetics Business Overview
11.2.3 Fulgent Genetics Expanded Carrier Screening Introduction
11.2.4 Fulgent Genetics Revenue in Expanded Carrier Screening Business (2015-2020)
11.2.5 Fulgent Genetics Recent Development
11.3 LabCorp
11.3.1 LabCorp Company Details
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Expanded Carrier Screening Introduction
11.3.4 LabCorp Revenue in Expanded Carrier Screening Business (2015-2020)
11.3.5 LabCorp Recent Development
11.4 VCGS
11.4.1 VCGS Company Details
11.4.2 VCGS Business Overview
11.4.3 VCGS Expanded Carrier Screening Introduction
11.4.4 VCGS Revenue in Expanded Carrier Screening Business (2015-2020)
11.4.5 VCGS Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Details
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Expanded Carrier Screening Introduction
11.5.4 Myriad Genetics Revenue in Expanded Carrier Screening Business (2015-2020)
11.5.5 Myriad Genetics Recent Development
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Details
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Expanded Carrier Screening Introduction
11.6.4 Eurofins Scientific Revenue in Expanded Carrier Screening Business (2015-2020)
11.6.5 Eurofins Scientific Recent Development
11.7 BGI Genomics
11.7.1 BGI Genomics Company Details
11.7.2 BGI Genomics Business Overview
11.7.3 BGI Genomics Expanded Carrier Screening Introduction
11.7.4 BGI Genomics Revenue in Expanded Carrier Screening Business (2015-2020)
11.7.5 BGI Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Jul, 2020
  • NO OF PAGES: 134